IMMUTEP LIMITED — Director's Dealing 2009

Sep 16, 2009

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

	PRIMA BIOMED LIMITED (ASX: PRR)
Name of Entity:
	90 009 237 889
ABN:

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: MR. ATA GOKYILDIRIM Date of Last Notice: 19[th] August 2009

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or Indirect Interest		Indirect	Indirect
Nature of Indirect Interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		Director Related Entity
Date of change		16thSeptember	2009
No. of securities held prior to change				Options - 23,464,285 23,464,285
			Shares	Options
		Direct	-	-
		Indirect	234,000	23,464,285
		Total	234,000	23,464,285
Class		Fully Paid Ordinary Shares (PRR)
Number Acquired				Options - - -
			Shares	Options
		Direct	-	-
		Indirect	13,500,000	-
		Total	13,500,000	-

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number Disposed				Options - 13,500,000 13,500,000
			Shares	Options
		Direct	-	-
		Indirect	-	13,500,000
		Total	-	13,500,000
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		Nil
No. of Securities Held After Change				Options - 9,964,285 9,964,285
			Shares	Options
		Direct	-	-
		Indirect	13,734,000	9,964,285
		Total	13,734,000	9,964,285
Nature of Change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Exercise of PRRAO Unlisted Options, vesting 15thSeptember 2009, exercisable for nil consideration on or before 30th September 2009.

Part 2 – Change of Director’s Interests in Contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of Contract Nature of Interest Name of Registered Holder (if issued securities) Date of Change No. and Class of Securities to Which Interest Related Prior to Change Note: Details are only required for a contract in relation to which the interest has changed Interest Acquired Interest Disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest After Change

==> picture [54 x 32] intentionally omitted <==

The CFO Solution

17.09.2009

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

	PRIMA BIOMED LIMITED (ASX: PRR)
Name of Entity:
	90 009 237 889
ABN:

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: MR. MARTIN ROGERS

Date of Last Notice: 19[th] August 2009

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or Indirect Interest		Indirect	Indirect
Nature of Indirect Interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		Director related entity
Date of change		16thSeptember 2009
No. of securities held prior to change				Options - 32,345,238 32,345,238
			Shares	Options
		Direct	-	-
		Indirect	497,500	32,345,238
		Total	497,500	32,345,238
Class		Fully Paid	Ordinary Shares (PRR)
Number Acquired				Options - - -
			Shares	Options
		Direct	-	-
		Indirect	20,000,000	-
		Total	20,000,000	-

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number Disposed				Options - 20,000,000 20,000,000
			Shares	Options
		Direct	-	-
		Indirect	-	20,000,000
		Total	-	20,000,000
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		Nil Consideration
No. of Securities Held After Change				Options - 12,345,238 12,345,238
			Shares	Options
		Direct	-	-
		Indirect	20,497,500	12,345,238
		Total	20,497,500	12,345,238
Nature of Change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Exercise of PRRAO Unlisted Options, vesting 15thSeptember 2009, exercisable for nil consideration on or before 30th September 2009.

Part 2 – Change of Director’s Interests in Contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of Contract
Nature of Interest
Name of Registered Holder (if issued securities)
Date of Change
No. and Class of Securities to Which Interest Related Prior to Change Note: Details are only required for a contract in relation to which the interest has changed
Interest Acquired
Interest Disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest After Change

==> picture [54 x 32] intentionally omitted <==

The CFO Solution

17.09.2009

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

	PRIMA BIOMED LIMITED (ASX: PRR)
Name of Entity:
	90 009 237 889
ABN:

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: DR. RICHARD HAMMEL Date of Last Notice: 19[th] August 2009

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or Indirect Interest		Indirect	Indirect
Nature of Indirect Interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		Director Related Entity
Date of change		16thSeptember 2009
No. of securities held prior to change				Options - 12,619,047 12,619,047
			Shares	Options
		Direct	-	-
		Indirect	-	12,619,047
		Total	-	12,619,047
Class		Fully Paid	Ordinary Shares (PRR)
Number Acquired				Options - - -
			Shares	Options
		Direct	-	-
		Indirect	5,000,000	-
		Total	5,000,000	-

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number Disposed			Shares	Options
		Direct	-	-
		Indirect	-	5,000,000
		Total	-	5,000,000
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		Nil
No. of Securities Held After Change				Options - 7,619,047 7,619,047
			Shares	Options
		Direct	-	-
		Indirect	5,000,000	7,619,047
		Total	5,000,000	7,619,047
Nature of Change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Exercise of PRRAO Unlisted Options, vesting 15thSeptember 2009, exercisable for nil consideration on or before 30th September 2009.

Part 2 – Change of Director’s Interests in Contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

part.
Detail of Contract
Nature of Interest
Name of Registered Holder (if issued securities)
Date of Change
No. and Class of Securities to Which Interest Related Prior to Change Note: Details are only required for a contract in relation to which the interest has changed
Interest Acquired
Interest Disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest After Change

==> picture [24 x 15] intentionally omitted <==

17.09.2009

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002